With 53543.0 shares changed hands, the volume of the stock remained lighter than its average volume of 91170.0 shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.6371 whereas the lowest price it dropped to was $2.5. The 52-week range on ANIX shows that it touched its highest point at $5.13 and its lowest point at $2.14 during that stretch. It currently has a 1-year price target of $8.50. Beta for the stock currently stands at 0.87.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ANIX was down-trending over the past week, with a drop of -5.84%, but this was down by -19.38% over a month. Three-month performance dropped to -18.10% while six-month performance rose 8.86%. The stock lost -33.85% in the past year, while it has lost -33.51% so far this year. A look at the trailing 12-month EPS for ANIX yields -0.39 with Next year EPS estimates of -0.36. For the next quarter, that number is -0.09. This implies an EPS growth rate of -23.44% for this year and 7.59% for next year.
Float and Shares Shorts:
At present, 32.15 million ANIX shares are outstanding with a float of 30.55 million shares on hand for trading. On 2024-11-29, short shares totaled 0.37 million, which was 114.99999999999999 higher than short shares on 1730332800. In addition to Dr. Amit Kumar Ph.D. as the firm’s CEO, Chairman & Co-Chair of CBAB, Mr. Michael J. Catelani CPA, MBA serves as its President, COO, CFO & Corporate Secretary.
Institutional Ownership:
Through their ownership of 0.17459999 of ANIX’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-07-31, ANIX reported revenue of $0.0 and operating income of -$3592000.0. The EBITDA in the recently reported quarter was -$3589000.0 and diluted EPS was -$0.1.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ANIX since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With ANIX analysts setting a high price target of 10.0 and a low target of 7.0, the average target price over the next 12 months is 8.5. Based on these targets, ANIX could surge 287.6% to reach the target high and rise by 171.32% to reach the target low. Reaching the average price target will result in a growth of 229.46% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.395 being high and -$0.395 being low. For ANIX, this leads to a yearly average estimate of -$0.395. Based on analyst estimates, the high estimate for the next quarter is -$0.11 and the low estimate is -$0.11. The average estimate for the next quarter is thus -$0.11.
